|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-15
|
$1,428,925
|
$171,471
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-08S1
|
$200,000
|
$24,000
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
5U54CA137788-08
|
$1,073,287
|
$128,794
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S1
|
$34,031
|
$2,722
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S2
|
$250,000
|
$20,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S3
|
$124,997
|
$10,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-07
|
$1,495,000
|
$119,600
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$679,152
|
$135,830
|
Anderson, Stephen
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$261,157
|
$130,578
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
5P01CA018029-40
|
$4,225,448
|
$2,197,233
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$76,885
|
$15,377
|
Arthur, Diane
|
CCR (NCI)
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-15S1
|
$901,656
|
$54,099
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
$3,675
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
$3,750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
$6,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
$1,875
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
$334,876
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-37
|
$259,426
|
$103,770
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
5R01CA072669-18
|
$294,076
|
$294,076
|
BLAZAR, BRUCE
|
UNIVERSITY OF MINNESOTA
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-05
|
$170,100
|
$170,100
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
|
3R01CA183605-03S1
|
$374,707
|
$374,707
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
5R01CA183605-03
|
$536,875
|
$536,875
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVH
|
1R44CA192601-01A1
|
$1,059,489
|
$1,059,489
|
BUI, LYNNE
|
TARGAZYME, INC.
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
1P30CA196521-01
|
$1,695,000
|
$84,750
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
1R01CA184728-01A1
|
$401,456
|
$401,456
|
CAO, XUEFANG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy
|
5K08CA174750-02
|
$178,740
|
$178,740
|
CAPITINI, CHRISTIAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
5K08CA169485-03
|
$171,372
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Intervention of Immune Tolerance by Small Molecules
|
5R01CA127483-07
|
$341,161
|
$341,161
|
CHEN, SHU-HSIA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
|
1R21CA198776-01
|
$202,275
|
$202,275
|
CHOI, SUNG
|
UNIVERSITY OF MICHIGAN
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-05
|
$151,059
|
$151,059
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetic Therapy for Fanconi Anemia
|
5R01CA155294-05
|
$319,550
|
$159,775
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Defining the role of macrophages in the progression of human cutaneous squamous c
|
5K08CA172580-04
|
$148,492
|
$148,492
|
COLEGIO, OSCAR
|
YALE UNIVERSITY
|
|
Biobehavioral Mechanisms Facilitating Recovery From Stem Cell Transplantation
|
5K07CA136966-05
|
$148,785
|
$37,196
|
COSTANZO, ERIN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$749
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$31,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
2P01CA142106-11A1
|
$1,685,462
|
$1,685,462
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$625
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$1,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$77,044
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S1
|
$120,000
|
$4,800
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S2
|
$123,768
|
$4,951
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S3
|
$60,000
|
$2,400
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S4
|
$200,000
|
$8,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
5P30CA016672-40
|
$10,405,362
|
$416,214
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
5R01CA077544-14
|
$533,838
|
$533,838
|
DIAMOND, DON
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-02
|
$710,976
|
$710,976
|
DIAMOND, DON
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-02
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-02
|
$161,608
|
$161,608
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA091842-14
|
$4,305,712
|
$43,057
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
Total relevant funding to Organ Transplantation Research for this search: $48,711,965
|